Financial statements Tumor3D
Balance sheet data of TUMOR3D
|
Year
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|
| Total assets | 20 626 097,60 | 35 644 845,42 | 14 825 074,14 | 14 508 406,55 |
| A. Fixed assets | 2 039 077,92 | 7 468 141,38 | 9 795 405,28 | 8 472 874,74 |
| B. Current assets | 18 587 019,68 | 28 176 704,04 | 5 029 668,86 | 6 035 531,81 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 20 626 097,60 | 35 644 845,42 | 14 825 074,14 | 14 508 406,55 |
| A. Equity | 10 149 354,86 | 20 284 774,04 | 12 150 821,98 | 10 459 041,35 |
| B. Liabilities and provisions for liabilities | 10 476 742,74 | 15 360 071,38 | 2 674 252,16 | 4 049 365,20 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 10 435 774,10 | 15 319 102,74 | 2 580 808,58 | 3 585 644,03 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.